NOVAST Laboratories, Limited (SZSE: 301569)
Salud · Farmacéuticas · CN
16,73 CN¥
-2,96 % hoy · -52,4 % 1 año
NOVAST Laboratories, Limited (SZSE: 301569) opera en la industria de farmacéuticas dentro del sector salud. Su valor en bolsa es de 2,24 mil M $ y tiene 697 empleados.
En los últimos doce meses la acción ha bajado un 52,4 % y ha cotizado entre 16,73 y 42,15.
Tweenvest puntúa a NOVAST Laboratories, Limited en cuatro factores: calidad 83/100, valor 4/100, crecimiento 52/100. Su punto más fuerte es calidad.
Evolución de la cotización de 301569
Cifras clave
- Capitalización
- 2,24 mil M $
- Ingresos (últ. 12 m)
- 150,54 M $
- PER
- 40,88
- BPA
- 0,27
- Rent. por dividendo
- —
- Beta (5 años)
- —
- Máximo 52 semanas
- 42,15 CN¥
- Mínimo 52 semanas
- 16,73 CN¥
- Volumen medio (3 m)
- —
- Acciones en circulación
- 891,60 M
- Empleados
- 697
- Próximos resultados
- —
Sobre NOVAST Laboratories, Limited
NOVAST Laboratories, Limited develops, manufactures, and sells prescription drug formulations. The company produces controlled-release formulations, including extended-release and sustained-release tablets and capsules, as well as low-dose drug formulations. Its products include Metoprolol Succinate Extended-Release Tablets, Nifedipine Extended-Release Tablets, Diltiazem Hydrochloride Extended-Release Capsules, Metformin Hydrochloride Sustained-Release Tablets, Levonorgestrel Tablets, Memantine Hydrochloride Extended-Release Capsules, Quetiapine Fumarate Sustained-Release Tablets, and Tolterodine tablets for urinary frequency and urgency. The company also develops a digestive-system extended-release tablet designated DG-062. Additionally, the company provides formulation contract research organization (CRO) services, including prescription process development and regulatory filing and clinical support services for pharmaceutical companies and research institutions, as well as outsourced CRO and contract manufacturing organization (CMO) services for innovative drugs. NOVAST Laboratories, Limited was incorporated in 2005 and is based in Nantong, China.
- ISIN
- CNE1000080W6
- Fundada en
- 2005
- Cotiza desde
- 15 oct 2026
- Bolsa
- Shenzhen Stock Exchange
- Divisa
- CNY
Otras empresas de farmacéuticas
| Empresa | Capitalización | Precio | Día |
|---|---|---|---|
| Aether Industries LimitedNSEI: AETHER | 2,36 mil M $ | 1677,20 Rs | -0,72 % |
| China Resources Jiangzhong Pharmaceutical Co.,LtdSHSE: 600750 | 2,30 mil M $ | 24,40 CN¥ | +2,18 % |
| Shandong Buchang Pharmaceuticals Co., Ltd.SHSE: 603858 | 2,28 mil M $ | 14,65 CN¥ | -1,61 % |
| Pharvaris N.V.NasdaqGS: PHVS | 2,28 mil M $ | 32,44 $ | -2,76 % |
| Zhejiang Hisun Pharmaceutical Co., Ltd.SHSE: 600267 | 2,23 mil M $ | 12,87 CN¥ | -3,52 % |
| Tonghua Dongbao Pharmaceutical Co., Ltd.SHSE: 600867 | 2,23 mil M $ | 7,60 CN¥ | -0,65 % |
| Perrigo Company plcNYSE: PRGO | 2,23 mil M $ | 16,04 $ | -5,31 % |
| Jamjoom Pharmaceuticals Factory CompanySASE: 4015 | 2,22 mil M $ | 119,20 SR | +1,79 % |